An Indole-2-Carboxamide Derivative, LG4, Alleviates Diabetic Kidney Disease Through Inhibiting MAPK-Mediated Inflammatory Responses

An Indole-2-Carboxamide Derivative, LG4, Alleviates Diabetic Kidney Disease Through Inhibiting MAPK-Mediated Inflammatory Responses

Jianchang Qian,1,* Sihui Yin,1,* Lin Ye,1 Zhe Wang,2 Sheng Shu,1,3 Zhenxin Mou,1,3 Mingjiang Xu,1 Nipon Chattipakorn,4 Zhiguo Liu,1 Guang Liang1,3,5 1Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of Chi...

Full description

Bibliographic Details
Main Authors: Qian J, Yin S, Ye L, Wang Z, Shu S, Mou Z, Xu M, Chattipakorn N, Liu Z, Liang G
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:Journal of Inflammation Research
Subjects:
indole-2-carboxamide derivative
diabetic kidney disease
inflammation
mapk
nf-κb
Online Access:https://www.dovepress.com/an-indole-2-carboxamide-derivative-lg4-alleviates-diabetic-kidney-dise-peer-reviewed-fulltext-article-JIR

Internet

https://www.dovepress.com/an-indole-2-carboxamide-derivative-lg4-alleviates-diabetic-kidney-dise-peer-reviewed-fulltext-article-JIR

Similar Items